Stockscreener 앱 받기
1.94
3.00%
-0.06
시간 외 거래:
1.91
-0.03
-1.55%
전일 마감가:
$2.00
열려 있는:
$2.01
하루 거래량:
90,908
Relative Volume:
0.51
시가총액:
$17.42M
수익:
$66.38M
순이익/손실:
$-14.18M
주가수익비율:
-0.691
EPS:
-2.8074
순현금흐름:
$-5.17M
1주 성능:
-5.83%
1개월 성능:
-18.49%
6개월 성능:
-4.43%
1년 성능:
+30.20%
1일 변동 폭
$1.905
$2.06
1주일 범위
$1.905
$2.30
52주 변동 폭
$0.95
$2.82
Aytu Biopharma Inc Stock (AYTU) Company Profile
명칭
Aytu Biopharma Inc
전화
(720) 437-6580
주소
7900 E. UNION AVENUE, DENVER
AYTU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
1.94 | 20.38M | 66.38M | -14.18M | -5.17M | -2.8074 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 개시 | Lake Street | Buy |
| 2025-06-30 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-29 | 개시 | H.C. Wainwright | Buy |
Aytu Biopharma Inc 주식(AYTU)의 최신 뉴스
Why Aytu BioPharma Inc. (AY20) stock is trending on social mediaOil Prices & Real-Time Stock Entry Alerts - newser.com
Will Aytu BioPharma Inc. (AY20) stock profit from fiscal stimulusJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
Is Aytu BioPharma Inc. stock cheap at current valuationJuly 2025 Selloffs & AI Driven Price Predictions - newser.com
What risks investors should watch in Aytu BioPharma Inc. stockPortfolio Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Pre Market Movers: NUTX, AYTU, NOTV Swing Big - RTTNews
What MACD signals say about Aytu BioPharma Inc.July 2025 Update & Low Drawdown Trading Techniques - newser.com
Why Aytu BioPharma Inc. stock remains resilientJuly 2025 Outlook & Short-Term Trading Alerts - newser.com
Regression analysis insights on Aytu BioPharma Inc. performance2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
Aytu BioPharma : Corporate Presentation November 2025 View Presentation - MarketScreener
How Aytu BioPharma Inc. (AY20) stock moves in volatile trading sessionsDay Trade & Daily Technical Stock Forecast Reports - newser.com
Will Aytu BioPharma Inc. stock attract more institutional investorsWeekly Volume Report & Community Shared Stock Ideas - newser.com
Aytu BioPharma, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Aytu BioPharma Inc AY20 Stock Analysis and ForecastMACD Histogram Signals & Superior Trading Ideas - earlytimes.in
How to escape a deep drawdown in Aytu BioPharma Inc.Market Activity Report & High Accuracy Investment Signals - newser.com
Does Aytu BioPharma Inc. qualify in momentum factor screeningTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
Is Aytu BioPharma Inc. stock ready for a breakoutTake Profit & Low Drawdown Investment Ideas - newser.com
Will Aytu BioPharma Inc. stock see insider buyingMarket Growth Review & Consistent Profit Trading Strategies - newser.com
Relative strength of Aytu BioPharma Inc. in sector analysisWeekly Profit Recap & Verified Momentum Stock Watchlist - newser.com
Understanding Aytu BioPharma Inc.’s price movementJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Aytu BioPharma outlines $10M EXXUA launch investment and targets breakeven at $17.3M quarterly revenue as ADHD franchise holds strong - MSN
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2026 Earnings Call Transcript - Insider Monkey
Will Aytu BioPharma Inc. (AY20) stock keep high P E multiples2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Earnings call transcript: Aytu BioPharma’s Q1 2025 shows stable stock By Investing.com - Investing.com Australia
Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ... By GuruFocus - Investing.com Canada
Aytu BioPharma Reports Q1 2026 Earnings and EXXUA Launch Plans - TipRanks
Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Stro - GuruFocus
Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ... - Yahoo Finance
Transcript : Aytu BioPharma, Inc., Q1 2026 Earnings Call, Nov 13, 2025 - MarketScreener
Earnings call transcript: Aytu BioPharma's Q1 2025 shows stable stock By Investing.com - Investing.com UK
Earnings call transcript: Aytu BioPharma’s Q1 2025 shows stable stock - Investing.com
Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
AYTU BIOPHARMA, INC SEC 10-Q Report - TradingView
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results - ACCESS Newswire
Real time social sentiment graph for Aytu BioPharma Inc.Earnings Growth Summary & Weekly High Conviction Ideas - newser.com
Can Aytu BioPharma Inc. (AY20) stock deliver consistent EPS growthProfit Target & AI Powered Market Entry Strategies - newser.com
Aytu Biopharma Inc (AYTU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.17%
0.67%
자본화:
|
볼륨(24시간):